Blog Posts

Fri, Mar 6, 2026

Forget consumer neobanks. I’m looking at the B2B infrastructure plays positioned for a 2026 rerating. Here is my data-driven shortlist.

Thu, Mar 5, 2026

$TTD crashed 76% from highs. Trading at $30 with a $59 analyst consensus. Here's why I think it doubles.

Thu, Mar 5, 2026

I found 3 cybersecurity stocks positioned for a major shift as new federal mandates and AI data risks converge this March.

Tue, Mar 3, 2026

I’m tracking three Aerospace & Defense stocks positioned for a rerating as the FY2026 budget hits the tape. Here is my data-driven plan.

Mon, Mar 2, 2026

My data-driven deep dive into the three nuclear energy stocks I'm watching for a 2026 breakout. No hype, just the numbers.

Tue, Feb 17, 2026

AI fears are crushing old economy stocks. But the rotation is creating real opportunities. 3 stocks I'm watching right now.

Tue, Feb 17, 2026

A look at my research process for finding asymmetric nuclear stocks before the March 2026 CERAWeek catalyst. No hype, just data.

Sun, Feb 15, 2026

Companies report "adjusted" profits while losing money on paper. Here's what Adjusted EBITDA actually hides.

Thu, Feb 5, 2026

I’m moving away from speculative biotech and focusing on these three oncology stocks with real revenue and upcoming 2026 catalysts.

Thu, Jan 15, 2026

Is UUUU a 10x opportunity or a trap? We analyze the US rare earth monopoly, 2026 catalysts, and critical risks before you invest.

Tue, Dec 23, 2025

Is ONON the next Lululemon? We analyze the 65% margins, the "LightSpray" catalyst, and the critical inventory red flag to watch in 2026.

Fri, Dec 19, 2025

A personal walk-through of how I’m researching clean energy stocks going into 2026… quietly.

Wed, Dec 17, 2025

Everyone is chasing AI hype. I’m looking at the 2026 regulatory deadline. Here are the 3 stocks positioned to profit from mandatory compliance.

Wed, Dec 17, 2025

Big Pharma faces a $200B revenue hole in 2026. Here are the 3 cash-rich, commercial-stage stocks I'm tracking to play the coming M&A wave.

Thu, Dec 11, 2025

Oracle dropped 12% on earnings despite a massive backlog. Here is the forensic audit of the $523B RPO, the negative cash flow, and why this setup screams 10x potential.

Fri, Dec 5, 2025

Everyone is watching the cloud. I'm watching the devices that run it. Here are 3 hardware stocks positioned for a major rotation in December 2025.

Thu, Dec 4, 2025

The DOE just signaled a shift in nuclear energy. Here are the 3 stocks I'm tracking for December 2025, from miners to tech disruptors.

Mon, Dec 1, 2025

Credo (CRDO) just reported 272% YoY revenue growth and raised guidance massively. Here’s the forensic audit of the numbers you need to know.

Wed, Nov 26, 2025

Meta won its legal war, ads are booming.. But Zuck is spending $72B a year on AI. Here is why the math says this is a strong buy.

Tue, Nov 25, 2025

The Artemis II launch is approaching. Here are the 3 commercial space stocks I'm analyzing for a potential 2026 breakout, focusing on data over hype.

Mon, Nov 24, 2025

While the market chases consumer apps, I'm looking at the infrastructure quietly powering the holiday spend. Here are the 3 stocks on my December radar.

Sat, Nov 22, 2025

Subsidies are gone and the market hates battery stocks. That's exactly why I'm looking at these three companies for December 2025

Wed, Nov 19, 2025

NVDA posted $57B in revenue and raised guidance to $65B. The "Air Pocket" thesis is dead. Here is my deep-dive analysis of the Q3 numbers.

Wed, Nov 19, 2025

The sector is facing a massive regulatory deadline in December. Here is the data on the 3 companies I'm tracking to play the supply chain crunch.

Wed, Nov 19, 2025

The oncology sector is waking up. Here are 3 high-conviction stocks I'm watching before the major December conferences shake up the market.